Seelaus Asset Management LLC Cuts Holdings in Avantor, Inc. (NYSE:AVTR)

Seelaus Asset Management LLC decreased its holdings in Avantor, Inc. (NYSE:AVTR) by 22.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,505 shares of the company’s stock after selling 2,710 shares during the period. Seelaus Asset Management LLC’s holdings in Avantor were worth $200,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of AVTR. State Street Corp raised its stake in shares of Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after acquiring an additional 8,206,695 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in Avantor by 653.0% in the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after acquiring an additional 5,354,678 shares in the last quarter. FMR LLC grew its holdings in Avantor by 557.2% in the third quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after purchasing an additional 3,963,912 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of Avantor by 18.2% during the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after purchasing an additional 2,719,615 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Avantor by 146.5% during the 3rd quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock valued at $67,996,000 after purchasing an additional 1,562,018 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Trading Down 11.8 %

NYSE AVTR opened at $19.15 on Friday. Avantor, Inc. has a 1 year low of $19.08 and a 1 year high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The company has a market capitalization of $13.03 billion, a PE ratio of 41.63, a P/E/G ratio of 3.87 and a beta of 1.28. The company has a fifty day moving average of $21.73 and a 200 day moving average of $23.44.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter last year, the business earned $0.22 EPS. Research analysts forecast that Avantor, Inc. will post 0.98 earnings per share for the current year.

Wall Street Analyst Weigh In

AVTR has been the topic of several research analyst reports. Wells Fargo & Company dropped their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Barclays boosted their price target on Avantor from $25.00 to $26.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. UBS Group reaffirmed a “neutral” rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Robert W. Baird dropped their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Finally, Raymond James decreased their price target on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a report on Tuesday, January 21st. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and an average target price of $27.46.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.